Reflexion Health logo

Reflexion Health Funding & Investors

Hayward, CA

RefleXion Medical, Inc. operates as a medical device company. The Company develops biologically-guided radiation therapy systems for treating solid tumors in the body. RefleXion Medical produces products by leveraging its positron emission tomography that allows tumors to continuously signal their location during treatment.

https://reflexion.com/

Total Amount Raised: $675,099,968

Reflexion Health Funding Rounds

  • Series Unknown

    $105,000,000

    Series Unknown Investors

    The Rise Fund
    Johnson & Johnson Innovation – JJDC
    Hillenbrand Capital Partners, LLC.
    Ally Bridge Group
    Pfizer Venture Investments
    Pictet Private Equity Investors
    Squarepoint Capital
    Venrock
    T. Rowe Price
    Catalio Capital Management
  • Debt Financing

    $125,000,000

  • Series Unknown

    $80,000,000

    Series Unknown Investors

    Ascension Health
    Sixty Degree Capital
    Hillenbrand Capital Partners, LLC.
    Catalio Capital Management
    Johnson & Johnson Innovation – JJDC
    Ally Bridge Group
    Venrock
    The Rise Fund
    T. Rowe Price
    KCK
    Pfizer Venture Investments
    PSP Investments
  • Series D

    $40,000,000

    Series D Investors

    Ally Bridge Group
  • Series D

    $100,000,000

    Series D Investors

    PSP Investments
    The Rise Fund
    T. Rowe Price
    Pfizer Venture Investments
    KCK
    Venrock
    Johnson & Johnson Innovation – JJDC
    Sofinnova Partners
  • Debt Financing

    $60,000,000

    Debt Financing Investors

    Oxford Finance
  • Series C

    $100,000,000

    Series C Investors

    The Rise Fund
    Johnson & Johnson Robotics and Digital Solutions
    Pfizer Venture Investments
    T. Rowe Price
    GT Healthcare Capital Partners
    Sofinnova Partners
    KCK
    Venrock
  • Series B

    $52,000,000

    Series B Investors

    KCK
    Pfizer Venture Investments
    Venrock
    Sofinnova Partners
    Johnson & Johnson Robotics and Digital Solutions
  • Grant

    $1,500,000

    Grant Investors

    National Cancer Institute (NCI)
  • Series A

    $11,600,000

    Series A Investors

    Sofinnova Partners
    Pfizer Venture Investments
    Venrock
Funding info provided by Diffbot.